PrEP therapies utter new hope in HIV preventive landscape as vaccine failures amass
Research in HIV is shifting towards pre-exposure prophylaxis (PrEP) therapies due to vaccine failures. Major pharmaceutical companies have faced setbacks in developing an AIDS vaccine. Dr.